Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bram Priem

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Nature Nanotechnology|February 3, 2025
Nature-inspired platform nanotechnology for RNA delivery to myeloid cells and their bone marrow progenitorsStijn R J Hofstraat, Tom Anbergen, Robby Zwolsman, et al.
Nature Nanotechnology|July 31, 2024
Polymersomes with splenic avidity target red pulp myeloid cells for cancer immunotherapyAnnelies C Wauters, Jari F Scheerstra, Mandy M T van Leent, et al.
Science Advances|January 1, 2026
Systemically inducing trained immunity overcomes solid tumors' immunosuppressive microenvironmentBram Priem, Lisa Willemsen, Tom Anbergen, et al.
Iscience|April 3, 2025
Targeting mTOR in myeloid cells prevents infection-associated inflammationYohana C Toner, Jazz Munitz, Geoffrey Prevot, et al.
Cell|October 30, 2020
Trained Immunity-Promoting Nanobiologic Therapy Suppresses Tumor Growth and Potentiates Checkpoint InhibitionBram Priem, Mandy M T van Leent, Abraham J P Teunissen, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Nature Nanotechnology|February 3, 2025
Nature-inspired platform nanotechnology for RNA delivery to myeloid cells and their bone marrow progenitorsStijn R J Hofstraat, Tom Anbergen, Robby Zwolsman, et al.
Nature Nanotechnology|July 31, 2024
Polymersomes with splenic avidity target red pulp myeloid cells for cancer immunotherapyAnnelies C Wauters, Jari F Scheerstra, Mandy M T van Leent, et al.
Science Advances|January 1, 2026
Systemically inducing trained immunity overcomes solid tumors' immunosuppressive microenvironmentBram Priem, Lisa Willemsen, Tom Anbergen, et al.
Iscience|April 3, 2025
Targeting mTOR in myeloid cells prevents infection-associated inflammationYohana C Toner, Jazz Munitz, Geoffrey Prevot, et al.
Cell|October 30, 2020
Trained Immunity-Promoting Nanobiologic Therapy Suppresses Tumor Growth and Potentiates Checkpoint InhibitionBram Priem, Mandy M T van Leent, Abraham J P Teunissen, et al.
Pageof 2